Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 11.30% is in line with its 5-year average of 10.42%, around the middle of its 5-year range (7.90%–13.71%).
8.39% above its 12-month average of 10.43%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 2.81%.
RETURN ON ASSETS (ROA)
11.30%
RETURN ON ASSETS (ROA) AVG TTM
10.43%
RETURN ON ASSETS (ROA) AVG 3Y
10.23%
RETURN ON ASSETS (ROA) AVG 5Y
10.42%
RETURN ON ASSETS (ROA) AVG 10Y
9.19%
RETURN ON ASSETS (ROA) AVG 15Y
8.28%
RETURN ON ASSETS (ROA) AVG 20Y
7.33%
CURRENT VS TTM AVG
+8.39%
CURRENT VS 3Y AVG
+10.41%
CURRENT VS 5Y AVG
+8.39%
CURRENT VS 10Y AVG
+22.94%
CURRENT VS 15Y AVG
+36.49%
CURRENT VS 20Y AVG
+54.06%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+119.84%
vs the sector median at left
HCA Healthcare, Inc.
Market Cap
$91.60B
Return on Assets (ROA)
11.30%
TTM Avg
10.43%
3Y Avg
10.23%
5Y Avg
10.42%
Market Cap
$90.77B
Return on Assets (ROA)
3.93%
TTM Avg
4.89%
3Y Avg
5.25%
5Y Avg
5.41%
Market Cap
$80.01B
Return on Assets (ROA)
10.37%
TTM Avg
11.40%
3Y Avg
12.40%
5Y Avg
16.97%
Market Cap
$104.67B
Return on Assets (ROA)
5.20%
TTM Avg
5.08%
3Y Avg
5.08%
5Y Avg
2.52%
Market Cap
$106.77B
Return on Assets (ROA)
7.78%
TTM Avg
6.88%
3Y Avg
7.02%
5Y Avg
6.41%
Market Cap
$76.15B
Return on Assets (ROA)
4.08%
TTM Avg
2.99%
3Y Avg
3.50%
5Y Avg
3.82%
Market Cap
$65.30B
Return on Assets (ROA)
8.11%
TTM Avg
5.66%
3Y Avg
4.50%
5Y Avg
3.49%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HCA Healthcare, Inc. (HCA) | $91.60B | 11.30% | 10.43% | 10.23% | 10.42% |
| Elevance Health Inc. (ELV)vs › | $90.77B | 3.93% | 4.89% | 5.25% | 5.41% |
| GSK plc (GSK)vs › | $99.95B | 7.91% | 6.85% | 11.28% | 9.07% |
| Sanofi (SNY)vs › | $102.48B | 3.12% | 5.18% | 5.31% | 6.19% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $80.01B | 10.37% | 11.40% | 12.40% | 16.97% |
| McKesson Corporation (MCK)vs › | $104.67B | 5.20% | 5.08% | 5.08% | 2.52% |
| Stryker Corporation (SYK)vs › | $106.77B | 7.78% | 6.88% | 7.02% | 6.41% |
| Cigna Corporation (CI)vs › | $76.15B | 4.08% | 2.99% | 3.50% | 3.82% |
| Boston Scientific Corporation (BSX)vs › | $65.30B | 8.11% | 5.66% | 4.50% | 3.49% |
| Medtronic plc (MDT)vs › | $119.48B | 5.61% | 5.13% | 4.62% | 4.65% |
ROA
11.3%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 11.17% |
| 2024-12-31 | 9.68% |
| 2023-12-31 | 9.33% |
| 2022-12-31 | 10.76% |
| 2021-12-31 | 13.71% |
| 2020-12-31 | 7.90% |
| 2019-12-31 | 7.78% |
| 2018-12-31 | 9.66% |
| 2017-12-31 | 6.06% |
| 2016-12-31 | 8.56% |
| 2015-12-31 | 6.50% |
| 2014-12-31 | 6.01% |
| 2013-12-31 | 5.40% |
| 2012-12-31 | 5.72% |
| 2011-12-31 | 9.16% |
| 2010-12-31 | 5.06% |
| 2009-12-31 | 4.37% |
| 2008-12-31 | 2.77% |
| 2007-12-31 | 3.64% |
| 2006-12-31 | 4.38% |
| 2005-12-31 | 6.41% |
| 2004-12-31 | 5.80% |
| 2003-12-31 | 6.32% |
| 2002-12-31 | 4.44% |
| 2001-12-31 | 5.00% |
| 2000-12-31 | 1.66% |
| 1999-12-31 | 4.38% |
| 1998-12-31 | 2.42% |
| 1997-12-31 | -1.39% |
| 1996-12-31 | 7.08% |
